Cite
Commentary on the MID3 Good Practices Paper.
MLA
Manolis, Efthymios, et al. “Commentary on the MID3 Good Practices Paper.” CPT: Pharmacometrics & Systems Pharmacology, vol. 6, no. 7, July 2017, pp. 416–17. EBSCOhost, https://doi.org/10.1002/psp4.12223.
APA
Manolis, E., Brogren, J., Cole, S., Hay, J. L., Nordmark, A., Karlsson, K. E., Lentz, F., Benda, N., Wangorsch, G., Pons, G., Zhao, W., Gigante, V., Serone, F., Standing, J. F., Dokoumetzidis, A., Vakkilainen, J., van den Heuvel, M., Mangas Sanjuan, V., Taminiau, J., & Kerwash, E. (2017). Commentary on the MID3 Good Practices Paper. CPT: Pharmacometrics & Systems Pharmacology, 6(7), 416–417. https://doi.org/10.1002/psp4.12223
Chicago
Manolis, Efthymios, Jacob Brogren, Susan Cole, Justin L. Hay, Anna Nordmark, Kristin E. Karlsson, Frederike Lentz, et al. 2017. “Commentary on the MID3 Good Practices Paper.” CPT: Pharmacometrics & Systems Pharmacology 6 (7): 416–17. doi:10.1002/psp4.12223.